of the Company and its subsidiary increased by Baht 332.84 million or 13.01% compared with last year. An increase mainly caused by trade accounts receivable of Baht 119.56 million due to sales

April 1, 2018 to September 30, 2018 net profit, a decrease in full in long-term loan repayment to financial institutions by Baht 40.36 million, and a Baht 45.24 million decline in trade and other payables

Operating Fee for trade mark in China and the change on accounting record of the audit fee expense etc.  Finance Cost Q1/2019, the Company and its subsidiaries had the financial cost 1.1 MB decreased by 1.8

by 4.3% due to trade payables, net of cash received of short-term loans and repayment of long-term loans. Total shareholders’ equity presented at Baht 1,842.5 million, decreased by 1.6% from the

%. Current assets decreased by 7.8% from trade accounts receivable. Non-current assets increased by 0.2% due to investment in cold repair furnace B. Total liabilities decreased by 2.5% due to trade payables

134.3 million mostly from trade payables and short-term loans of Baht 224.6 million to support higher production. Meanwhile, long- term liabilities decreased by Baht 97 million for the repayment. As a

assets of consolidated financial statements increased by Baht 214.33 million or 8.38% compared with last year. An increase mainly caused by trade accounts receivable of Baht 76.6 million as sales increased

long-term loan repayment to financial institutions by Baht 49.72 million, and a Baht 20.51 million decline in trade and other payables, which was mainly บริษัท ดโีอด ีไบโอเทค จ ำกดั (มหำชน) 111 หมู่ที่ 2

-period decrease in finance costs was because of a principle repayment and a reducing loan interest rates. Net profits The Company booked net profits of Baht 47.24 million and Baht 33.43 million in the six

Y/2020 % Cash and cash equivalents 53.68 6.60% 44.97 5.20% Short-term loan from financial institution - - 122.00 14.12% Trade and other receivables 60.63 7.45% 67.65 7.83% Trade and other payables